Literature DB >> 623854

Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder.

A I Barkai, D L Dunner, H A Gross, P Mayo, R R Fieve.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 623854

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  18 in total

1.  Evaluation of Myo-Inositol as a Potential Biomarker for Depression in Schizophrenia.

Authors:  Joshua Chiappelli; Laura M Rowland; S Andrea Wijtenburg; Florian Muellerklein; Malle Tagamets; Robert P McMahon; Frank Gaston; Peter Kochunov; L Elliot Hong
Journal:  Neuropsychopharmacology       Date:  2015-02-27       Impact factor: 7.853

2.  Perinatal n-3 fatty acid deficiency selectively reduces myo-inositol levels in the adult rat PFC: an in vivo (1)H-MRS study.

Authors:  Robert K McNamara; Jessica Able; Ronald Jandacek; Therese Rider; Patrick Tso; Diana M Lindquist
Journal:  J Lipid Res       Date:  2008-09-18       Impact factor: 5.922

3.  CSF inositol does not predict antidepressant response to inositol. Short communication.

Authors:  J Levine; L Kurtzman; A Rapoport; J Zimmerman; Y Bersudsky; J Shapiro; R H Belmaker; G Agam
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Epi-inositol and inositol depletion: two new treatment approaches in affective disorder.

Authors:  Y Bersudsky; H Einat; Z Stahl; R H Belmaker
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

5.  Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate.

Authors:  Nicolas Fayed; Javier Garcia-Campayo; Rosa Magallón; Helena Andrés-Bergareche; Juan V Luciano; Eva Andres; Julián Beltrán
Journal:  Arthritis Res Ther       Date:  2010-07-07       Impact factor: 5.156

Review 6.  Inositol for depressive disorders.

Authors:  M J Taylor; H Wilder; Z Bhagwagar; J Geddes
Journal:  Cochrane Database Syst Rev       Date:  2004

7.  Magnetic resonance spectroscopic imaging in the era of pseudoprogression and pseudoresponse in glioblastoma patient management.

Authors:  Hyunsuk Shim; Chad A Holder; Jeffrey J Olson
Journal:  CNS Oncol       Date:  2013-09

Review 8.  Inositol depletion, GSK3 inhibition and bipolar disorder.

Authors:  Wenxi Yu; Miriam L Greenberg
Journal:  Future Neurol       Date:  2016-04-26

9.  Variations in myo-inositol in fronto-limbic regions and clinical response to electroconvulsive therapy in major depression.

Authors:  Stephanie Njau; Shantanu H Joshi; Amber M Leaver; Megha Vasavada; Jessica Van Fleet; Randall Espinoza; Katherine L Narr
Journal:  J Psychiatr Res       Date:  2016-05-28       Impact factor: 4.791

Review 10.  The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence.

Authors:  F Ferrari; R F Villa
Journal:  Mol Neurobiol       Date:  2016-08-10       Impact factor: 5.590
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.